Regulatory
Breakthrough Therapy
An FDA designation that expedites development of drugs with preliminary evidence of substantial improvement over existing therapy.
Definition
Breakthrough designation grants intensive FDA guidance and eligibility for rolling review. It has been granted to several peptide drugs in oncology and metabolic disease.
Related terms
Back to the full peptide glossary.